Komori
Statutory disclosure document4572Carna Biosciences,Inc.Pharmaceuticals

Report on the Transfer of Shares Allotted Through a Third-Party Allotment

Athos Asia Event Driven Master Fund, the allottee under the third-party allotment, transferred 349,400 of the shares in the Company that had been allotted to it to Macquarie Bank Limited. The allottee continues to enjoy the economic gains and losses from those shares after the transfer.

Worth reading
54Recurring
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
349400
Shares
Wording
Definitive
How definitive the wording is.

Decision and Details

Transfer of shares allotted through a third-party allotment

Implementation13 April 2026 (actual)
AmountTransfer price: ¥412 per share
Quantity / scaleNumber of shares allotted: 900,000 shares; number of shares transferred: 349,400 shares; cumulative number of shares transferred: 900,000 shares (as of 13 April 2026)
Reason

The shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.

Decision and Details
ItemDetails
Matter CoveredTransfer of shares allotted through a third-party allotment
Implementation Date13 April 2026 (actual)
AmountTransfer price: ¥412 per share
Quantity / scaleNumber of shares allotted: 900,000 shares; number of shares transferred: 349,400 shares; cumulative number of shares transferred: 900,000 shares (as of 13 April 2026)
ReasonThe shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.
Related previous disclosuresThe allotment of shares in the Company through a third-party allotment on 31 May 2024
Items this document does not state (6)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleFuture plans

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on the Transfer of Shares Allotted Through a Third-Party Allotment | Carna Biosciences,Inc. (4572) timely disclosure | Komori